serw-MX  [xml]  
 


    
 DeCS Categories

C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.284 DNA Repair-Deficiency Disorders .
C18.452.284.600 Nijmegen Breakage Syndrome .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.695 Receptors, G-Protein-Coupled .
D12.776.543.750.695.900 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.695.910 Receptors, Vasopressin .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.408 Integrins .
D12.776.543.750.705.408.850 Receptors, Very Late Antigen .
D12.776.543.750.720 Receptors, Neurotransmitter .
D12.776.543.750.720.600 Receptors, Neuropeptide .
D12.776.543.750.720.600.915 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.720.600.925 Receptors, Vasopressin .
D12.776.543.750.750 Receptors, Peptide .
D12.776.543.750.750.360 Receptors, Gastrointestinal Hormone .
D12.776.543.750.750.360.900 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.750.555 Receptors, Neuropeptide .
D12.776.543.750.750.555.915 Receptors, Vasoactive Intestinal Peptide .
D12.776.543.750.750.555.925 Receptors, Vasopressin .
D12.776.543.750.750.660 Receptors, Pituitary Hormone .
D12.776.543.750.750.660.900 Receptors, Vasopressin .
D12.776.543.750.830 Receptors, Virus .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Receptors, Vasopressin .
8-Arg-Vasopressin Receptor .
Antidiuretic Hormone Receptor .
Antidiuretic Hormone Receptor 1a .
Antidiuretic Hormone Receptor 1b .
Arginine Vasopressin Receptor .
Argipressin Receptor .
Argipressin Receptors .
Receptor, Arginine(8)-Vasopressin .
Renal-Type Arginine Vasopressin Receptor .
V1 Receptor .
V1a Vasopressin Receptor .
V1b Vasopressin Receptor .
V2 Receptor .
Vascular-Hepatic Type Arginine Vasopressin Receptor .
Vasopressin Receptor .
Vasopressin Receptor 1 .
Vasopressin Type 1A Receptor .
Vasopressin V1a Receptor .
Vasopressin V1b Receptor .
Vasopressin V2 Receptor .
Vasopressin V3 Receptor .
8 Arg Vasopressin Receptor .
Hormone Receptor, Antidiuretic .
Hormone Receptors, Antidiuretic .
Receptor, Antidiuretic Hormone .
Receptor, Arginine Vasopressin .
Receptor, Argipressin .
Receptor, V1 .
Receptor, V2 .
Receptor, Vasopressin .
Receptor, Vasopressin V1b .
Receptor, Vasopressin V3 .
Receptors, Antidiuretic Hormone .
Receptors, Argipressin .
Renal Type Arginine Vasopressin Receptor .
V1b Receptor, Vasopressin .
Vascular Hepatic Type Arginine Vasopressin Receptor .
Vasopressin Receptor, V1b .
Antidiuretic Hormone Receptors .
Receptors, V1 .
Receptors, V2 .
Vasopressin Receptors .
V1 Receptors .
V2 Receptors .
Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors. .
1.00
 
Receptors, Virus .
Receptors, Phage .
Phage Receptors .
Virus Receptors .
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. .
0.56
 
Nijmegen Breakage Syndrome .
At-V1 .
Ataxia-Telangiectasia Variant 1 .
Ataxia-Telangiectasia Variant V1 .
Berlin Breakage Syndrome .
Immunodeficiency, Microcephaly, And Chromosomal Instability .
Microcephaly with Normal Intelligence, Immunodeficiency, and Lymphoreticular Malignancies .
Nonsyndromal Microcephaly, Autosomal Recessive, with Normal Intelligence .
Seemanova Syndrome 2 .
Seemanova Syndrome II .
Ataxia Telangiectasia Variant 1 .
Ataxia Telangiectasia Variant V1 .
Ataxia-Telangiectasia Variant 1s .
Ataxia-Telangiectasia Variant V1s .
Breakage Syndrome, Berlin .
Breakage Syndrome, Nijmegen .
Syndrome, Berlin Breakage .
Syndrome, Nijmegen Breakage .
Variant 1s, Ataxia-Telangiectasia .
Variant V1, Ataxia-Telangiectasia .
Variant V1s, Ataxia-Telangiectasia .
A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N (RAD50/MRE11/NBS1) protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION. .
0.56
 
Receptors, Vasoactive Intestinal Peptide .
VIP Receptor .
Vasoactive Intestinal Peptide Receptor .
Receptor, VIP .
Receptors, VIP .
Vasoactive Intestinal Peptide Receptors .
VIP Receptors .
Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; (VIP); with high affinity and trigger intracellular changes which influence the behavior of cells. .
0.55
 
Receptors, Very Late Antigen .
Receptor, Very Late Antigen .
Receptors, Very Late Activation Antigen .
VLA Activation Antigens .
VLA Differentiation Antigens .
VLA Receptors .
Very Late Activation Antigen Receptors .
Very Late Antigen Receptors .
Activation Antigens, VLA .
Antigens, VLA Activation .
Antigens, VLA Differentiation .
Differentiation Antigens, VLA .
Protein Complex, VLA .
Receptors, VLA .
VLA Protein Complex .
Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six VLA antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits. .
0.52